非経口栄養剤市場：栄養素タイプ、剤形、エンドユーザー別-2025-2030年の世界予測

非経口栄養剤市場は、2023年に76億7,000万米ドルと評価され、2024年には83億3,000万米ドルに達すると予測され、CAGR 8.66％で成長し、2030年には137億3,000万米ドルになると予測されています。

非経口栄養剤（PN）とは、通常、病状により十分な栄養を摂取・吸収できない患者に対して、消化管をバイパスして血流に直接栄養を送り込むことです。PNの必要性は、胃腸障害のある患者、治療による副作用を経験している腫瘍患者、成長と発育に不可欠な栄養素を必要とする未熟児にまで及ぶ。PNは主に病院、外来診療所、在宅ヘルスケアで行われています。ヘルスケア技術の革新と、長期的な栄養補給を必要とする慢性疾患の有病率の上昇に牽引され、市場は需要を拡大しています。主な成長促進要因としては、栄養不良や消化器疾患の割合の増加、高度なヘルスケア・インフラ、栄養介入を必要とすることが多い高齢化人口の増加などが挙げられます。潜在的なビジネスチャンスは、患者ごとのカスタマイズ機能を強化した、より効率的で安全なPN製剤の開発にあります。ヘルスケア・インフラが整備されつつある新興国市場へのアクセス開拓も、大きな成長機会となります。しかし、PNソリューションの高コスト、複雑な規制当局の承認、感染症や代謝異常などの合併症のリスクといった課題が、市場拡大の妨げとなっています。PNの技術革新は、栄養素の生物学的利用能の向上、ヘルスケア関連リスクの低減、より良いモニタリングと管理のためのデジタルヘルス技術の採用に重点を置く可能性があります。高度なデータ分析と遺伝子情報を活用した個別化栄養ソリューションの調査は、市場成長の有望分野です。市場の競争は激しく、主要企業は製品の有効性と安全性を向上させるために絶えず技術革新を行っています。規制状況の変化や技術の進歩に遅れを取らないことは、この進化する状況で成功を目指す企業にとって極めて重要です。結論として、PN市場は、企業が戦略的イノベーションと未開拓地域への進出を通じて既存の課題を克服することができれば、大きな可能性を秘めています。

市場力学：急速に進化する非経口栄養剤市場の主要市場インサイトを公開

非経口栄養剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 腎臓病、肝臓病、がんなどの慢性疾患の流行
  • 老年人口と栄養不良人口の割合の増加
  • 世界の出生率の高さと早産
• 市場抑制要因
  • 非経口栄養剤の承認に関する政府の厳格な規則
• 市場機会
  • 革新的な非経口・経腸栄養療法
  • 非経口栄養剤の技術開発
• 市場の課題
  • 非経口栄養剤に付随する複雑性

ポーターの5つの力非経口栄養剤市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、非経口栄養剤市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：非経口栄養剤市場における外部からの影響の把握

外部マクロ環境要因は、非経口栄養剤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析非経口栄養剤市場における競合情勢の把握

非経口栄養剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス非経口栄養剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、非経口栄養剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨非経口栄養剤市場における成功への道筋を描く

非経口栄養剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腎臓病、肝臓病、がんなどの慢性疾患の有病率
    • 高齢者人口と栄養失調者の増加
    • 世界中で高出生率と早産が増加
  • 抑制要因
    • 非経口栄養剤の承認に関する政府の厳格な規則
  • 機会
    • 革新的な非経口および経腸栄養療法
    • 非経口栄養剤における技術開発
  • 課題
    • 非経口栄養剤に関連する複雑さ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 非経口栄養剤市場栄養素の種類別

• アミノ酸
• 炭水化物
• 電解質
• 脂質
• マルチビタミン配合と微量元素

第7章 非経口栄養剤市場剤形別

• アンプル
• バッグ
• ボトル
• バイアル

第8章 非経口栄養剤市場：エンドユーザー別

• クリニック
• 病院
• 長期介護サービス提供者

第9章 南北アメリカの非経口栄養剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の非経口栄養剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの非経口栄養剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• ACULIFE HEALTHCARE PRIVATE LIMITED
• ALBERT DAVID LIMITED by Kothari Group
• Amanta Healthcare Ltd.
• AMINO GmbH
• B. Braun Melsungen AG
• Baxter International Inc.
• Claris Lifesciences Limited
• Evonik Industries AG
• Fresenius Kabi AG
• Grifols S.A.
• Hamilton Bonaduz AG
• ICU Medical, Inc.
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Well Pharma Medical Solutions LLC

LIST OF FIGURES

• FIGURE 1. PARENTERAL NUTRITION MARKET RESEARCH PROCESS
• FIGURE 2. PARENTERAL NUTRITION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PARENTERAL NUTRITION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PARENTERAL NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PARENTERAL NUTRITION MARKET DYNAMICS
• TABLE 7. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LIPIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY MULTIVITAMIN FORMULATIONS & TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY AMPULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BAGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY LONG-TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. CANADA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PARENTERAL NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. CHINA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 51. CHINA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 54. INDIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. ITALY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 106. ITALY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. POLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 118. POLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. QATAR PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 121. QATAR PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY NUTRIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM PARENTERAL NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. PARENTERAL NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. PARENTERAL NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

The Parenteral Nutrition Market was valued at USD 7.67 billion in 2023, expected to reach USD 8.33 billion in 2024, and is projected to grow at a CAGR of 8.66%, to USD 13.73 billion by 2030.

Parenteral nutrition (PN) involves delivering nutrients directly into the bloodstream, bypassing the gastrointestinal tract, usually for patients unable to ingest or absorb enough nutrients due to medical conditions. The necessity of PN extends to patients with gastrointestinal disorders, oncology patients experiencing side effects from their treatment, and premature infants who require essential nutrients for growth and development. PN is primarily applied in hospitals, outpatient clinics, and home healthcare settings. Driven by innovations in healthcare technology and the rising prevalence of chronic diseases requiring long-term nutritional support, the market sees growing demand. Key growth drivers include the increasing rate of malnutrition and gastrointestinal diseases, advanced healthcare infrastructure, and a rise in the aging population that often requires nutritional interventions. Potential opportunities lie in the development of more efficient, safer PN formulations with enhanced patient-specific customization capabilities. Expanding access to emerging markets, where healthcare infrastructure is developing, also presents a significant growth opportunity. However, challenges such as the high cost of PN solutions, complex regulatory approvals, and risks of complications like infections and metabolic abnormalities hinder market expansion. Innovations in PN might focus on improving the bioavailability of nutrients, reducing healthcare-associated risks, and employing digital health technologies for better monitoring and administration. Research into personalized nutrition solutions, utilizing advanced data analytics and genetic information, offers a promising area for market growth. The market's nature is highly competitive, with key players constantly innovating to improve product efficacy and safety. Staying abreast of regulatory changes and technological advancements will be crucial for businesses aiming to succeed in this evolving landscape. In conclusion, the PN market holds significant potential, provided companies can navigate the existing challenges through strategic innovation and expansion into untapped regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Parenteral Nutrition Market

The Parenteral Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
  • Increasing rate of geriatric population and malnourished individuals
  • High natality and premature births around the globe
• Market Restraints
  • Strict government rules regarding the approval of parenteral nutrition
• Market Opportunities
  • Innovative parenteral and enteral nutrition therapy
  • Technological developments in parenteral nutrition
• Market Challenges
  • Associated complexities with parenteral nutrition

Porter's Five Forces: A Strategic Tool for Navigating the Parenteral Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Parenteral Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Parenteral Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Parenteral Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Parenteral Nutrition Market

A detailed market share analysis in the Parenteral Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Parenteral Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Parenteral Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Parenteral Nutrition Market

A strategic analysis of the Parenteral Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Parenteral Nutrition Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ACULIFE HEALTHCARE PRIVATE LIMITED, ALBERT DAVID LIMITED by Kothari Group, Amanta Healthcare Ltd., AMINO GmbH, B. Braun Melsungen AG, Baxter International Inc., Claris Lifesciences Limited, Evonik Industries AG, Fresenius Kabi AG, Grifols S.A., Hamilton Bonaduz AG, ICU Medical, Inc., Otsuka Holdings Co., Ltd., Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Well Pharma Medical Solutions LLC.

Market Segmentation & Coverage

This research report categorizes the Parenteral Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Nutrient Type, market is studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements.
• Based on Dosage Form, market is studied across Ampules, Bags, Bottles, and Vials.
• Based on End-User, market is studied across Clinics, Hospitals, and Long-Term Care Providers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
    • 5.1.1.2. Increasing rate of geriatric population and malnourished individuals
    • 5.1.1.3. High natality and premature births around the globe
  • 5.1.2. Restraints
    • 5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovative parenteral and enteral nutrition therapy
    • 5.1.3.2. Technological developments in parenteral nutrition
  • 5.1.4. Challenges
    • 5.1.4.1. Associated complexities with parenteral nutrition
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Parenteral Nutrition Market, by Nutrient Type

• 6.1. Introduction
• 6.2. Amino Acids
• 6.3. Carbohydrates
• 6.4. Electrolytes
• 6.5. Lipids
• 6.6. Multivitamin Formulations & Trace Elements

7. Parenteral Nutrition Market, by Dosage Form

• 7.1. Introduction
• 7.2. Ampules
• 7.3. Bags
• 7.4. Bottles
• 7.5. Vials

8. Parenteral Nutrition Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals
• 8.4. Long-Term Care Providers

9. Americas Parenteral Nutrition Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Parenteral Nutrition Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Parenteral Nutrition Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. ACULIFE HEALTHCARE PRIVATE LIMITED
• 3. ALBERT DAVID LIMITED by Kothari Group
• 4. Amanta Healthcare Ltd.
• 5. AMINO GmbH
• 6. B. Braun Melsungen AG
• 7. Baxter International Inc.
• 8. Claris Lifesciences Limited
• 9. Evonik Industries AG
• 10. Fresenius Kabi AG
• 11. Grifols S.A.
• 12. Hamilton Bonaduz AG
• 13. ICU Medical, Inc.
• 14. Otsuka Holdings Co., Ltd.
• 15. Pfizer Inc.
• 16. Sichuan Kelun Pharmaceutical Co., Ltd.
• 17. Well Pharma Medical Solutions LLC